Torray Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Torray Investment Partners's PFE Position: Q1 2026 in Review
Torray Investment Partners reduced its Pfizer (PFE) stake by 3.4% in Q1 2026, selling an estimated $722K and leaving 776,455 shares worth $21.8M. The position accounts for 3.2% of the portfolio, ranked #9.
Torray Investment Partners first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Torray Investment Partners held 776,455 shares of Pfizer worth $21.8M as of Q1 2026.
- Torray Investment Partners sold 27,116 Pfizer shares in Q1 2026, an estimated $722K.
- Pfizer made up 3.2% of Torray Investment Partners's portfolio in Q1 2026, its #9 holding.
- Torray Investment Partners first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.